{
    "nctId": "NCT00725374",
    "briefTitle": "A Study to Investigate the Effects of Tibolone (Livial\u00ae) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)",
    "officialTitle": "A Exploratory, Double-blind, Randomized, Placebo-controlled Trial to Investigate the Tissue Specific Effects of 2.5 mg Tibolone on Breast Cancer in Postmenopausal Women, in Particular on Breast Tissue Proliferation.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 102,
    "primaryOutcomeMeasure": "The primary objective of this trial was to compare changes in the expression of the proliferation marker Ki-67 in malignant breast tissue after treatment with tibolone or placebo.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* postmenopausal women of any age\n* requiring surgery for early invasive primary breast cancer (clinically stage I or II; T1-T3; N0-1; M0), with estrogen receptor-positive tumor(s)\n* body mass index between 18 and 2 kg/m2, inclusive\n* must be willing to give voluntary written informed consent.\n\nExclusion Criteria:\n\n* healthy subjects",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}